The leading drug formulation and delivery professionals across Europe will be gathering to examine the latest technological developments and strategic advancements affecting the industry.

This year’s multi-streamed sessions include:

Small Molecule Formulation & Delivery

• Successful Formulation Strategies in Achieving Novel Product Development
• Improving bioavailability of poorly soluble compounds
• Controlled release technologies

Biologics Formulation & Delivery

• Preventing aggregation and ensuring stability in biologic formulation
• Characterization of Biological Drug Products
• Biologic combination products – technical development and commercial drivers

Medical Device Development

• Implants and biodegradable device platforms in enhancing drug delivery
• Balancing device technology enhancement with patient usability
• Patient & technical considerations for device design

Emerging Technologies

• Applications of nanotechnology and particle size reduction in combating issues of bioavailability
• Maximising drug release control with polymer technologies
• Exploring different routes of administration in enhancing macromolecule delivery

Out-sourcing and in-licensing

• Successfully sourcing new technologies from both academia and the industry
• Successful partnership strategies in approaching, managing and maintaining effective partnerships

Regulations and Compliance

• Regulatory viewpoint on QbD in pharmaceutical development
• Effectively responding to the Paediatric Implementation Plan (PIP)

Click here to view World Drug Delivery and Formulation 2012 programme